Works matching IS 22351795 AND DT 2025 AND VI 14

Results: 35

Front & Back Matter.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 1, doi. 10.1159/000547085
Publication type:: Article

Society News.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 355, doi. 10.1159/000546742
Publication type:: Article

Society News.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 354, doi. 10.1159/000546282
Publication type:: Article

Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 241, doi. 10.1159/000545594

By:

Kudo, Masatoshi

Publication type:

Article

Erratum.

Published in:: 2025
Publication type:: Correction Notice

Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 286, doi. 10.1159/000542577

By:

Koroki, Keisuke;
Ogasawara, Sadahisa;
Izai, Ryo;
Yonemoto, Takuya;
Akatsuka, Teppei;
Miwa, Chihiro;
Yumita, Sae;
Inoue, Masanori;
Kobayashi, Kazufumi;
Kiyono, Soichiro;
Nakamura, Masato;
Kanogawa, Naoya;
Kondo, Takayuki;
Nakamoto, Shingo;
Nakada, Shinichiro;
Sakai, Nozomu;
Yokoyama, Masayuki;
Ohtsuka, Masayuki;
Kato, Naoya

Publication type:

Article

Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 302, doi. 10.1159/000542576

By:

Shao, Yu-Yun;
Akhmetzhanov, Andrei R.

Publication type:

Article

Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 271, doi. 10.1159/000542099

By:

Ueshima, Eisuke;
Sofue, Keitaro;
Kodama, Takahiro;
Yamamoto, Shuhei;
Komatsu, Masato;
Komatsu, Shohei;
Ishihara, Nobuaki;
Umeno, Akihiro;
Yamaguchi, Takeru;
Hori, Masatoshi;
Fukumoto, Takumi;
Takehara, Tetsuo;
Murakami, Takamichi

Publication type:

Article

Letter to "Preoperative Prediction of Microvascular Invasion by EOB-MRI Imaging for Surgical Decision".

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 351, doi. 10.1159/000541884

By:

Tung, Hung-Ning;
Wu, Chih-Horng;
Su, Tung-Hung

Publication type:

Article

Long-Term Outcome of a Multicenter Prospective Study on Efficacy and Safety of High-Dose Stereotactic Body Radiation Therapy ≥48-h Interfraction Interval for ≤5 cm Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 248, doi. 10.1159/000541685

By:

Kang, Jin-Kyu;
Kim, Mi-Sook;
Jang, Won Il;
Han, Chul Ju;
Kim, Jin;
Park, Su Cheol;
Shin, Young-Joo;
Choi, Chul Won;
Jeon, Wan;
Yu, Tosol;
Chang, Ah Ram;
Park, Hae Jin;
Park, Younghee;
Kim, Eun Seog;
Jo, Sunmi;
Kim, Woo Chul;
Kim, Hun Jung;
Bae, Sun Hyun;
Kim, Eunji

Publication type:

Article

Probability of Lymph Node Metastases in Patients Undergoing Adequate Lymphadenectomy during Surgery for Intrahepatic Cholangiocarcinoma: A Retrospective Multicenter Study.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 260, doi. 10.1159/000541646

By:

Sposito, Carlo;
Cucchetti, Alessandro;
Ratti, Francesca;
Alaimo, Laura;
Ardito, Francesco;
Di Sandro, Stefano;
Serenari, Matteo;
Berardi, Giammauro;
Maspero, Marianna;
Ettorre, Giuseppe Maria;
Cescon, Matteo;
Di Benedetto, Fabrizio;
Giuliante, Felice;
Ruzzenente, Andrea;
Ercolani, Giorgio;
Aldrighetti, Luca;
Mazzaferro, Vincenzo

Publication type:

Article

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 311, doi. 10.1159/000541622

By:

Yang, Yu;
Sun, Juxian;
Cai, Jianqiang;
Chen, Minshan;
Dai, Chaoliu;
Wen, Tianfu;
Xia, Jinglin;
Ying, Mingang;
Zhang, Zhiwei;
Zhang, Xuewen;
Fang, Chihua;
Shen, Feng;
An, Ping;
Cai, Qingxian;
Cao, Jingyu;
Zeng, Zhen;
Chen, Gang;
Chen, Juan;
Chen, Ping;
Chen, Yongshun

Publication type:

Article

Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 334, doi. 10.1159/000540857

By:

Bi, Xinyu;
Lu, Yinying;
Chen, Bo;
Yang, Zhengqiang;
Hong, Zhixian;
Wang, Hanping;
Sun, Yongkun;
Wang, Xiaodong;
Yuan, Chunwang;
Zeng, Daobing;
Huang, Zhen;
Zhou, Aiping;
Zhang, Wen;
Du, Shunda;
Zhao, Jianjun;
Zhou, Jianguo;
Zhai, Yirui;
Che, Xu;
Zhao, Hong;
Zhao, Haitao

Publication type:

Article

The 14th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2024).

Published in:: Liver Cancer (2235-1795), 2025, v. 14, p. 1, doi. 10.1159/000543665
Publication type:: Article

Front & Back Matter.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 1, doi. 10.1159/000545991
Publication type:: Article

Treatment Decision-Making in Unresectable Hepatocellular Carcinoma: Importance of Understanding the Different Response Patterns between IO plus Anti-VEGF and IO plus IO Regimens.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 119, doi. 10.1159/000545163

By:

Kudo, Masatoshi

Publication type:

Article

Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 193, doi. 10.1159/000541647

By:

Nam, Heechul;
Sung, Pil Soo;
Lee, Sung Won;
Song, Do Seon;
Kwon, Jung Hyun;
Jang, Jeong Won;
Kim, Chang Wook;
Bae, Si Hyun

Publication type:

Article

Society News.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 239, doi. 10.1159/000545092
Publication type:: Article

The Impact of Radiation Dose and Tumour Burden on Outcomes in Hepatocellular Carcinoma: 11-Year Experience in a 413-Patient Cohort Treated with Yttrium-90 Resin Microsphere Radioembolisation.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 158, doi. 10.1159/000541539

By:

Chen, Kaina;
Tong, Aaron K.T.;
Moe, Fiona N.N.;
Ng, David C.E.;
Lo, Richard H.G.;
Gogna, Apoorva;
Yan, Sean X.;
Thang, Sue Ping;
Loke, Kelvin S.H.;
Venkatanarasimha, Nanda Karaddi;
Huang, Hian Liang;
Too, Chow Wei;
Ong, Timothy S.K.;
Yeo, Eng Xuan;
Peh, Daniel Yang Yao;
Ng, Ashley W.Y.;
Yang, Lu;
Chan, Wan Ying;
Chang, Jason P.E.;
Goh, Brian K.P.

Publication type:

Article

Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 180, doi. 10.1159/000541621

By:

Yang, Jiwon;
Choi, Won-Mook;
Kim, Hyung-Don;
Choi, Jonggi;
Yoo, Changhoon;
Lee, Danbi;
Shim, Ju Hyun;
Kim, Kang Mo;
Lim, Young-Suk;
Lee, Han Chu

Publication type:

Article

Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus Immunotherapy.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 142, doi. 10.1159/000541300

By:

Xu, Bin;
Wang, Lu-Na;
Wang, Zi-Yi;
He, Tian;
Zhu, Xiao-Dong;
Shen, Ying-Hao;
Zhou, Jian;
Fan, Jia;
Sun, Hui-Chuan;
Huang, Cheng

Publication type:

Article

Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380

By:

Inoue, Masanori;
Ogasawara, Sadahisa;
Kobayashi, Kazufumi;
Okubo, Tomomi;
Itokawa, Norio;
Obu, Masamichi;
Fujimoto, Kentaro;
Unozawa, Hidemi;
Yumita, Sae;
Fujiwara, Kisako;
Nakagawa, Miyuki;
Kanzaki, Hiroaki;
Koroki, Keisuke;
Kiyono, Soichiro;
Nakamura, Masato;
Kanogawa, Naoya;
Kondo, Takayuki;
Nakamoto, Shingo;
Nagashima, Kengo;
Itobayashi, Ei

Publication type:

Article

Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 223, doi. 10.1159/000541249

By:

Bi, Xinyu;
Zhao, Haitao;
Zhao, Hong;
Li, Guangming;
Wang, Xiaodong;
Chen, Bo;
Zhang, Wen;
Che, Xu;
Huang, Zhen;
Han, Yue;
Jiang, Liming;
Sun, Yongkun;
Yang, Zhengqiang;
Zhou, Jianguo;
Zhang, Yefan;
Zhu, Zhenyu;
Chen, Minshan;
Cheng, Shuqun;
Cai, Jianqiang

Publication type:

Article

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 127, doi. 10.1159/000540969

By:

Lee, Choong-kun;
Yoo, Changhoon;
Hong, Jung Yong;
Park, Se Jun;
Kim, Jin Won;
Tai, David Wai Meng;
Kim, Hyeyeong;
Korphaisarn, Krittiya;
Tanasanvimon, Suebpong;
Chen, San-Chi;
Kim, Ju Won;
Kim, Ilhwan;
Kim, Moonho;
Choo, Joan;
Oh, Sang-Bo;
Chen, Ching-Tso;
Bae, Woo Kyun;
Kim, Hongsik;
Huh, Seok Jae;
Yen, Chia-Jui

Publication type:

Article

Particle Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study, Systematic Review and Meta-Analysis.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 2, p. 211, doi. 10.1159/000540291

By:

Mizumoto, Masashi;
Shibuya, Kei;
Terashima, Kazuki;
Murakami, Masao;
Murakami, Motohiro;
Shioyama, Yoshiyuki;
Matsuo, Yoshiro;
Ogino, Takashi;
Ohno, Tatsuya;
Waki, Takahiro;
Ogino, Hiroyuki;
Tamamura, Hiroyasu;
Katoh, Norio;
Wakatsuki, Masaru;
Okimoto, Tomoaki;
Suzuki, Motohisa;
Saito, Takashi;
Toyama, Shingo;
Hashimoto, Takayuki;
Ohba, Hisateru

Publication type:

Article

Front & Back Matter.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 1, doi. 10.1159/000545516
Publication type:: Article

Society News.

Published in:: Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 117, doi. 10.1159/000543424
Publication type:: Article

Lenvatinib plus Pembrolizumab Combined with Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 1, doi. 10.1159/000543245

By:

Kudo, Masatoshi

Publication type:

Article

Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 104, doi. 10.1159/000541181

By:

Han, Ji Won;
Kang, Min Woo;
Lee, Soon Kyu;
Yang, Hyun;
Kim, Ji Hoon;
Yoo, Jae-Sung;
Cho, Hee Sun;
Jang, Eun Ji;
Seo, Deok Hwa;
Kwon, Jung Hyun;
Nam, Soon Woo;
Bae, Si Hyun;
Jang, Jeong Won;
Choi, Jong Young;
Yoon, Seung Kew;
Sung, Pil Soo

Publication type:

Article

The Impact of Normal Hepatobiliary Cell Zonation Programs on the Phenotypes and Functions of Primary Liver Tumors.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 92, doi. 10.1159/000541077

By:

Aoki, Tomoko;
Nishida, Naoshi;
Minami, Yasunori;
Kudo, Masatoshi

Publication type:

Article

Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 80, doi. 10.1159/000540858

By:

Shinkawa, Hiroji;
Kaibori, Masaki;
Ueno, Masaki;
Yasuda, Satoshi;
Ikoma, Hisashi;
Aihara, Tsukasa;
Nakai, Takuya;
Kinoshita, Masahiko;
Kosaka, Hisashi;
Hayami, Shinya;
Matsuo, Yasuko;
Morimura, Ryo;
Nakajima, Takayoshi;
Nobori, Chihoko;
Ishizawa, Takeaki

Publication type:

Article

M2BPGi Correlated with Immunological Biomarkers and Further Stratified Recurrence Risk in Patients with Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 68, doi. 10.1159/000540802

By:

Lee, I-Cheng;
Lei, Hao-Jan;
Wang, Lei-Chi;
Yeh, Yi-Chen;
Chau, Gar-Yang;
Hsia, Cheng-Yuan;
Chou, Shu-Cheng;
Luo, Jiing-Chyuan;
Hou, Ming-Chih;
Huang, Yi-Hsiang

Publication type:

Article

Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 58, doi. 10.1159/000540290

By:

Abou-Alfa, Ghassan K.;
Meyer, Tim;
Do, Richard Kinh Gian;
Piha-Paul, Sarina A.;
Light, Joseph S.;
Sherrin, Scott;
Yaqubie, Amin;
O'Neill, Alison Clemens;
Harding, James J.;
Al-Rajabi, Raed;
Denlinger, Crystal S.;
Cano, Pablo;
Cornelius, Albert S.;
O'Reilly, Eileen M.;
DiPrimeo, Daniel;
Eli, Lisa D.;
Gordan, John D.;
Solit, David B.

Publication type:

Article

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 36, doi. 10.1159/000540180

By:

Toshida, Katsuya;
Itoh, Shinji;
Iseda, Norifumi;
Tanaka, Shugo;
Nakazono, Kensuke;
Tomiyama, Takahiro;
Yoshiya, Shohei;
Toshima, Takeo;
Harada, Noboru;
Kohashi, Kenichi;
Taniguchi, Koji;
Oda, Yoshinao;
Yoshizumi, Tomoharu

Publication type:

Article

Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study.

Published in:

Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 19, doi. 10.1159/000539909

By:

Chen, Chi-Ling;
Yang, Wei-Shiung;
Yang, Hwai-I.;
Chen, Chuen-Fei;
Wang, Li-Yu;
Lu, Sheng-Nan;
Kao, Jia-Horng;
Chen, Pei-Jer;
Chen, Chien-Jen

Publication type:

Article